Clinical Trials Logo
  1. Home
  2. Analgesia
  3. NCT00762554
  4. Details
NCT00762554 Clinical Trial

Depodur vs Fentanyl Infusion for Post-C/S Analgesia

Analgesia Clinical Trial

Official title:
A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT00762554
Other study ID # goodman-1
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date October 2008
Est. completion date June 2009

Study information
Verified date March 2022
Source Goodman, Evan, M.D.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Epidurally administered Depodur provides equal or superior analgesia as an epidural infusion of fentanyl for the first 48 hours after a cesarean section.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date June 2009
Est. primary completion date June 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Healthy pregnant women (ASA I or II) who are scheduled for an elective cesarean section - Patient appropriate for regional anesthesia - Patient agrees to receive regional anesthesia - Patient willing to have an epidural infusion of medication for two days postoperatively Exclusion Criteria: - Morbid obesity - History of sleep apnea - Allergy to opioids medications - History of opioids use during week prior to procedure - Emergency cesarean section - Significant surgical complications - Contraindication or refusal to have regional anesthesia - Age less than 18

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Depodur
Depodur 10mg given epidurally at end of cesarean section.
• Depodur
Depodur 10mg given epidurally at end of cesarean section after patient received spinal bupivacaine at the beginning of the case.
• Fentanyl
Epidural fentanyl infusion started after spinal bupivacaine used for the cesarean section.

Locations
Country Name City State
United States University Hospitals Case Medical Center Cleveland Ohio

Sponsors (1)
Lead Sponsor Collaborator
Goodman, Evan, M.D.

Country where clinical trial is conducted

United States, 

References & Publications (2)

Carvalho B, Riley E, Cohen SE, Gambling D, Palmer C, Huffnagle HJ, Polley L, Muir H, Segal S, Lihou C, Manvelian G; DepoDur Study Group. Single-dose, sustained-release epidural morphine in the management of postoperative pain after elective cesarean delivery: results of a multicenter randomized controlled study. Anesth Analg. 2005 Apr;100(4):1150-1158. doi: 10.1213/01.ANE.0000149544.58230.FF. — View Citation

Carvalho B, Roland LM, Chu LF, Campitelli VA 3rd, Riley ET. Single-dose, extended-release epidural morphine (DepoDur) compared to conventional epidural morphine for post-cesarean pain. Anesth Analg. 2007 Jul;105(1):176-83. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Degree of analgesia (measured on a 10-point scale) 48 hours post-operatively
Secondary Frequency of minor side effects, such as pruritis or nausea. 48 hours postoperatively
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05534230 - Dexmedetomidine for Pain Reduction in CABG N/A
Recruiting NCT06275698 - HONEY for the Treatment of POst-Tonsillectomy Pain N/A
Recruiting NCT04436224 - Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation Phase 4
Not yet recruiting NCT04548323 - Hypoalgesic Effects of Walking and Running Imagined
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT04394481 - Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT05034601 - ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05454202 - Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
Recruiting NCT04554186 - Serratus Anterior Plane Block Versus Thoracic Paravertebral Block. N/A
Suspended NCT04860635 - Safety of F14 Following Total Knee Replacement Phase 2/Phase 3
Not yet recruiting NCT04519463 - The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing Early Phase 1
Completed NCT02916342 - Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks Phase 4
Not yet recruiting NCT02549118 - Tenoxicam for Intrapartum Analgesia Phase 2
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Not yet recruiting NCT02190760 - Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block. N/A
Completed NCT01789606 - Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet Phase 3
Completed NCT01299584 - ULTIVA Post Marketing Surveillance N/A
Completed NCT00137085 - Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation N/A